Curis
CRIS
#10277
Rank
NZ$40.11 M
Marketcap
NZ$1.00
Share price
-1.33%
Change (1 day)
-75.22%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.22. In 2024 the company made an earnings per share (EPS) of NZ-$11.91 an increase over its 2023 EPS that were of NZ-$15.30.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-46.43%
2024NZ-$11.91-22.15%
2023NZ-$15.30-26.17%
2022NZ-$20.7322.3%
2021NZ-$16.95-25.37%
2020NZ-$22.71-30.93%
2019NZ-$32.88-2.02%
2018NZ-$33.56
2016NZ-$76.27-10%
2015NZ-$84.74138.1%
2014NZ-$35.5940%
2013NZ-$25.42-25%
2012NZ-$33.9066.67%
2011NZ-$20.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.30-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.86-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.61-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$4.90-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.59 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.05 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.39-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA